Skip to main content
SpringerLink
Log in

A survey of the quality of generic clarithromycin products manufactured in Slovenia and Israel

  • Published:
Advances in Therapy Aims and scope Submit manuscript

Abstract

This study evaluated the quality of 11 generic clarithromycin products obtained in Poland, Slovakia, Slovenia, or Israel and manufactured in Slovenia or Israel. The generic products were examined visually, assayed by high-pressure liquid chromatography for clarithromycin content and impurities, tested for dissolution properties, and compared with the innovator product manufactured by Abbott Laboratories. Fifty-five percent of generic products fell short of the specifications for the innovator product. Ten percent of the generic products did not contain the amount of clarithromycin claimed in the label; 18% released less drug than did the branded tablets in the standard dissolution assay. In light of these results, it is not possible to conclude that all generic tablets are of the same quality as the innovator product; clinical trial results achieved with branded clarithromycin should not be extrapolated to generic products.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Langtry HD, Brogden RN. Clarithromycin. A review of its efficacy in the treatment of respiratory tract infections in immunocompetent patients.Drugs. 1997;53:973–1004.

    Article  PubMed  CAS  Google Scholar 

  2. Peters DH, Clissold SJ. Clarithromycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic potential.Drugs. 1992;44:117–164.

    Article  PubMed  CAS  Google Scholar 

  3. Bogossian M. Use of clarithromycin for respiratory infections in general practice.Rev Bras Med. 1995;52:500–509.

    Google Scholar 

  4. Farhat CK. Use of clarithromycin in respiratory infections in pediatrics.Mod Pediatr. 1995;31:1–8.

    Google Scholar 

  5. Endo LH. The use of clarithromycin in respiratory infections in general practice.Otorrinolaringologia. 1995;2:1–8.

    Google Scholar 

  6. Nightingale CH. A survey of the quality of generic clarithromycin products from 13 countries.Clin Drug Invest. 2000;19(4):293–305.

    Article  CAS  Google Scholar 

  7. Morgan DK, Brown DM, Rotsch TD, et al. A reversed-phase high-performance liquid chromatographic method for the determination and identification of clarithromycin as the drug substance and in various dosage forms.J Pharm Biomed Anal. 1991;9:261–269.

    Article  PubMed  CAS  Google Scholar 

  8. Morgan DK, Cugier P, Marello B, et al. Impurity profiling of clarithromycin using high-performance liquid chromatography with ultraviolet detection.J Chromatogr. 1990;502:351–358.

    Article  CAS  Google Scholar 

  9. Ishii K, Katayama Y, Itai S, et al. In vitro dissolution tests corresponding to the in vivo dissolution of clarithromycin tablets in the stomach and intestine.Chem Pharm Bull. 1995;43:1943–1948.

    PubMed  CAS  Google Scholar 

  10. Pharmacopeia of the United States of America. 23rd ed. Rockville, Md: US Pharmacopeial Convention; 1999.

  11. Brittain HG, ed.Analytical Profiles of Drug Substances, XXIV. New York: Academic Press; 1996.

    Google Scholar 

  12. CPMP/ICH/282/95 Step 4, Consensus Guideline, 6 November 1996.

Download references

Author information

Authors and Affiliations

  1. Institute of International Health Care Studies Hartford Hospital, University of Connecticut School of Pharmacy, Hartford, Connecticut

    C. H. Nightingale Ph.D. (Vice President for Research)

Authors
  1. C. H. Nightingale Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nightingale, C.H. A survey of the quality of generic clarithromycin products manufactured in Slovenia and Israel. Adv Therapy 17, 167–178 (2000). https://doi.org/10.1007/BF02853159

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02853159

Keywords

Search

Navigation